Trial intelligence / Profile preview

POLAR pilot study of pulsed dye laser, Er:YAG laser, and topical sirolimus for port-wine stain

NL-OMON40605Phase 4Recruiting

Sponsor
Erasmus MC
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of sirolimus in port-wine stain (4 arms), sponsored by Erasmus MC. Primary endpoint: Percentage clearance of the treated area assessed colorimetrically. Started Aug 2014; status: recruiting.

02

Drugs

sirolimus
03

Conditions

port-wine stain

Beyond the preview

Go deeper on NL-OMON40605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON40605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call